--- title: "BIO-Europe 2026 – Cologne" id: "2044" type: "post" slug: "bio-europe-2026-cologne" published_at: "2026-11-04T08:16:52+00:00" modified_at: "2026-11-04T08:24:35+00:00" url: "https://innocorepharma.com/news-events/bio-europe-2026-cologne/" markdown_url: "https://innocorepharma.com/news-events/bio-europe-2026-cologne.md" taxonomy_category: - "Events" --- 04 November 2026 | Events # BIO-Europe 2026 – Cologne # **Innocore Heads to Cologne for BIO-Europe 2026** Innocore will be attending BIO-Europe 2026, taking place from November 9–11 at Koelnmesse in Cologne, Germany, connecting with industry leaders, pharmaceutical companies and potential partners from across the global life sciences sector. BIO-Europe is one of Europe’s leading partnering events for the biotechnology and pharmaceutical industries, bringing together professionals to explore new collaborations, exchange knowledge and discuss developments in drug innovation. At Innocore, we specialize in the development of long-acting injectable drug delivery solutions, using our proprietary biodegradable polymer technologies to enable controlled and sustained drug release. Our participation in BIO-Europe provides a valuable opportunity to connect with potential partners, discuss development opportunities and explore how our technologies can support innovative pharmaceutical products. ### **Interested in meeting us at BIO-Europe 2026?** We welcome the opportunity to discuss potential collaborations and explore how Innocore’s expertise in long-acting drug delivery could support your development programs. Get in touch with [Martin Bakker](https://innocorepharma.com/company/people/martin-bakker/) to arrange a meeting during the event or send an email to [[email protected]](/cdn-cgi/l/email-protection#ef8d9a9c86818a9c9caf868181808c809d8a9f878e9d828ec18c8082) . ### **Event details** Date: November 9–11, 2026 Location: Koelnmesse, Cologne, Germany Official website: [https://informaconnect.com/bioeurope/](https://informaconnect.com/bioeurope/) Related insights [26 July 2018 | Funding InnoCore and Merck enter global collaboration Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology. Read the full story](https://innocorepharma.com/news-events/innocore-and-merck-enter-global-collaboration/) [11 September 2020 | Funding Bill & Melinda Gates Foundation Grant Awarded InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant. Read the full story](https://innocorepharma.com/news-events/innocore-awarded-grant-by-the-bill-melinda-gates-foundation-in-contraception/) [01 January 2021 | Funding InnoCore leads Consortium in Influenza vaccines InnoCore Pharmaceuticals has secured funding from the European Regional Development Fund to develop a biodegradable polymer-based microneedle array patch. Read the full story](https://innocorepharma.com/news-events/innocore-leads-consortium-in-influenza-vaccines/)